CAMBRIDGE, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it will participate in the following upcoming investor conferences:
H.C. Wainwright Cell Therapy Virtual Conference
Fireside Chat recording available on Tuesday, February 28, 2023 at 7:00 am ET
Inaugural Mizuho Oncology Therapeutics Summit
Panel: Developing & Commercializing Cell Therapy
Date: Monday, March 13, 2023 at 8:00 am
Location: Cadillac Hotel & Beach Club, Miami, FL
Oppenheimer 33rd Annual Virtual Healthcare Conference
Presentation: Monday, March 13, 2023 at 1:20 pm ET
Barclays Global Healthcare Conference
Fireside Chat: Wednesday, March 15, 2023 at 2:05 pm ET
Location: Loews Miami Beach Hotel, Miami, FL
A live webcast and archived replay of the presentation and fireside chats will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
